Qualify For a Study or Trial

The biggest obstacle in getting a celiac drug to market is recruiting enough patients to participate in clinical trials. Your participation is critical.

Take charge of your celiac disease to make better treatments and, one day, a cure for celiac disease a reality. Gain a better understanding of your celiac disease and how to manage it and potentially benefit from new medications or therapies that can improve your symptoms and your quality of life. See if you may qualify for a study or trial today!

 

Current Studies & Trials

U.S. Multi-Site

AVALON

AVALON is a phase 1 clinical trial assessing the investigational drug VTP-1000 in adults with celiac disease.

This investigational targeted immunotherapy is designed to prevent or reduce symptoms from accidental gluten exposure by promoting tolerance to gluten.

Eligibility Criteria:

  • 18–65 years old
  • Celiac disease confirmed by biopsy within the past 10 years
  • Have been on a gluten-free diet for 12+ months
  • US resident

Additional criteria apply, and compensation for your time and travel may be available.

Learn more at avalon.celiac.org.

See If You Qualify

It is important for patients to fully understand the potential risks and benefits of participating in a study or clinical trial and to discuss their options with their healthcare provider before making a decision. However, for many celiac patients, participation in a study or clinical trial can be a valuable and rewarding experience.

If you have questions about participating in a clinical trial or study listed here, please contact us at icureceliac@celiac.org or 844-593-8169 x121.